(DIR) Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
 (HTM) https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
 (DIR) MS Speaks
       *****************************************************
 (DIR)  Rebound syndrome in MS patients after stopping Gilenya
       6 replies
 (DIR) More skin cancer reported to FDA from patients on certain oral...
       0 replies
 (DIR) Randomized clinical trial: 2 fingolimod doses vs. Copaxone for...
       0 replies
 (DIR) MS patient on Gilenya with severe COVID-19 reported
       0 replies
 (DIR) (Abst.) Severe COVID-19 infection in patient w/MS treated w/fi...
       0 replies
 (DIR) Gilenya linked to slightly increased cancer risk, Swedish stud...
       0 replies
 (DIR) FDA approves first generics of Gilenya
       0 replies
 (DIR) Fingolimod and liver injury research information (PubMed)
       0 replies
 (DIR) (Abst.) Gilenya vs. Tecfidera in MS...
       0 replies
 (DIR) (Abst.) PML after fingolimod treatment
       1 replies
       *****************************************************
 (DIR) Next Page